RxDoctor Payments Data

Joseph Visceglia, PA

Physician Assistant · Lykens, PANPI 1477177525

Payments from drug & device makers

$4,667in general payments, 2019–2025

Across 280 payments — averaging $16.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$755
  • AbbVie$679
  • GSK$644
  • Pfizer$370
  • Dexcom, Inc.$240
  • Johnson & Johnson$224
  • plus $2K from 30 others

What the payments were for

  • Food & beverage$4,667100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,667 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$23,552
Medicare patients
106
Services billed
583

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin95$102,653
OzempicSemaglutide44$50,346
EliquisApixaban54$43,244
MounjaroTirzepatide34$39,651
Trelegy ElliptaFluticasone/Umeclidin/Vilanter54$33,677
TrulicityDulaglutide20$32,383
XareltoRivaroxaban18$21,699
FarxigaDapagliflozin Propanediol15$18,235
Breztri AerosphereBudesonide/Glycopyr/Formoterol13$10,893
TrintellixVortioxetine Hydrobromide17$8,216
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr13$7,914
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$5,764
Atorvastatin Calcium254$2,693
Albuterol Sulfate HfaAlbuterol Sulfate86$2,316
Metoprolol Succinate128$1,955

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance$52$102,65395 claims
Lilly USA, LLCMounjaro, Trulicity$77$72,03354 claims
Novo NordiskOzempic$755$50,34644 claims
PfizerEliquis$370$43,24454 claims
GSKTrelegy Ellipta, Anoro Ellipta$644$41,59167 claims
AstraZenecaFarxiga, Breztri Aerosphere$150$29,12928 claims
Johnson & JohnsonXarelto$224$21,69918 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$67$8,21617 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in Lykens

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →